<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Ventricular arrhythmias during pregnancy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Ventricular arrhythmias during pregnancy</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Ventricular arrhythmias during pregnancy</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Louise Harris, MBChB</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sing-Chien Yap, MD, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Candice Silversides, MD, MS, FRCPC</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Hugh Calkins, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Heidi M Connolly, MD, FACC, FASE</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Todd F Dardas, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 08, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H18809350"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Arrhythmias are the most common cardiac complication encountered during pregnancy in women with and without structural heart disease [<a href="#rid1">1-3</a>]. In the United States, the incidence of pregnancy-related hospitalizations with arrhythmias has increased between 2000 and 2012 primarily due to increases in the incidence of atrial fibrillation and ventricular tachycardia [<a href="#rid4">4</a>]. Arrhythmias may manifest for the first time during pregnancy, or pregnancy can trigger exacerbations in women with known preexisting arrhythmias [<a href="#rid1">1,5-7</a>]. </p><p>The prevalence, clinical presentation and management of ventricular arrhythmias will be reviewed. Cardiac arrest during pregnancy, general management of ventricular arrhythmias and cardiac arrest, electrocardiographic (ECG) characteristics of ventricular arrhythmias, and issues relating to supraventricular arrhythmias during pregnancy are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/14184.html" rel="external">"Sudden cardiac arrest and death in pregnancy"</a> and  <a class="medical medical_review" href="/d/html/920.html" rel="external">"Wide QRS complex tachycardias: Approach to the diagnosis"</a> and  <a class="medical medical_review" href="/d/html/278.html" rel="external">"Advanced cardiac life support (ACLS) in adults"</a> and  <a class="medical medical_review" href="/d/html/2119.html" rel="external">"ECG tutorial: Ventricular arrhythmias"</a> and  <a class="medical medical_review" href="/d/html/13600.html" rel="external">"Supraventricular arrhythmias during pregnancy"</a> and  <a class="medical medical_review" href="/d/html/101641.html" rel="external">"Wide QRS complex tachycardias: Approach to management"</a>.) </p><p class="headingAnchor" id="H15918746"><span class="h1">GENERAL APPROACH</span><span class="headingEndMark"> — </span>Women with established arrhythmias or structural heart disease are at highest risk of developing arrhythmias during pregnancy. Due to surgical advances, the number of women of childbearing age with congenital heart disease has increased and this group of women is at particularly high risk for arrhythmias  (<a class="graphic graphic_figure graphicRef61986" href="/d/graphic/61986.html" rel="external">figure 1</a>) [<a href="#rid1">1,2,8-12</a>] (see  <a class="medical medical_review" href="/d/html/1422.html" rel="external">"Pregnancy in women with congenital heart disease: General principles"</a>). Since arrhythmias are frequently associated with acquired or structural heart disease, any woman who presents with an arrhythmia during pregnancy should undergo clinical evaluation for structural heart disease (including an ECG and a transthoracic echocardiogram). (See <a class="local">'VT in women with structural heart disease'</a> below.)</p><p>In general, the approach to the treatment of arrhythmias in pregnancy is similar to that in the non-pregnant patient. However, due to the theoretical or known adverse effects of antiarrhythmic drugs on the fetus, antiarrhythmic drugs are generally reserved for the treatment of arrhythmias associated with significant symptoms or hemodynamic compromise [<a href="#rid13">13-15</a>]. Treatment strategies during pregnancy are hampered by the lack of randomized trials in this cohort of women. Choice of therapy, for the most part, is based on limited data from animal studies, case reports, observational studies, and clinical experience.</p><p>Use of antiarrhythmic drugs in pregnancy requires attention to potential alterations in pharmacokinetics as well as fetal risk. For most antiarrhythmic drugs, adequate and well-controlled studies in pregnant women are lacking, and therefore potential risks cannot be ruled out [<a href="#rid16">16,17</a>]. Another consideration is potential adverse effects in the infant during breastfeeding  (<a class="graphic graphic_table graphicRef50716" href="/d/graphic/50716.html" rel="external">table 1</a>). Antiarrhythmic drug safety during pregnancy, teratogenic risk, pharmacokinetic changes, and breastfeeding are discussed further separately. (See  <a class="medical medical_review" href="/d/html/13600.html" rel="external">"Supraventricular arrhythmias during pregnancy", section on 'Issues regarding antiarrhythmic drug treatment'</a>.) </p><p>The 2018 European Society of Cardiology Guidelines for the management of cardiovascular diseases during pregnancy and the 2023 Heart Rhythm Society expert consensus statement on the management of arrhythmias during pregnancy provide additional information regarding antiarrhythmic options [<a href="#rid16">16,18</a>]. </p><p class="headingAnchor" id="H18809358"><span class="h1">MECHANISM OF ARRHYTHMOGENESIS IN PREGNANCY</span><span class="headingEndMark"> — </span>The exact mechanism of increased arrhythmia burden during pregnancy is unclear but has been attributed to hemodynamic, hormonal, and autonomic changes related to pregnancy [<a href="#rid19">19</a>].</p><p>The hemodynamic changes of pregnancy have been well studied and these changes likely contribute to the development of arrhythmias during pregnancy [<a href="#rid20">20,21</a>]. Intravascular volume increases, augmenting the preload on the ventricles, and increasing both atrial and ventricular size [<a href="#rid20">20,22-25</a>]. Atrial and ventricular myocardial stretch may contribute to arrhythmogenesis due to stretch-activated ion channel activity causing membrane depolarization, shortened refractoriness, slowed conduction, and spatial dispersion of refractoriness and conduction [<a href="#rid26">26-29</a>]. There is also an increase in resting heart rate that has been associated with markers of arrhythmogenesis such as late potentials, premature ventricular contractions, and depressed heart rate variability [<a href="#rid30">30</a>]. (See  <a class="medical medical_review" href="/d/html/443.html" rel="external">"Maternal adaptations to pregnancy: Cardiovascular and hemodynamic changes"</a>.)</p><p>Few studies have been published on the influence of hormonal and autonomic changes on arrhythmogenesis in pregnancy. Although catecholamine levels do not appear to change during pregnancy, there is an increase in adrenergic responsiveness during pregnancy [<a href="#rid31">31-35</a>]. Estrogen has been shown to increase the number of myocardial alpha-adrenergic receptors [<a href="#rid36">36</a>]. This increased adrenergic activity may contribute to enhanced automaticity and triggered activity [<a href="#rid37">37</a>]. (See  <a class="medical medical_review" href="/d/html/952.html" rel="external">"Enhanced cardiac automaticity"</a>.)</p><p class="headingAnchor" id="H18809366"><span class="h1">PALPITATIONS</span><span class="headingEndMark"> — </span>Palpitations occur frequently during pregnancy and are a common indication for cardiac evaluation during pregnancy. The differential diagnosis of palpitations is extensive and the diagnostic evaluation of pregnant women with palpitations does not differ from nonpregnant women. (See  <a class="medical medical_review" href="/d/html/6835.html" rel="external">"Evaluation of palpitations in adults"</a>.)</p><p>One study compared 110 pregnant women with symptoms suggestive of possible arrhythmia (palpitations: 87 percent; dizziness: 13 percent; syncope/presyncope: 6 percent) with 52 pregnant women evaluated for an asymptomatic functional murmur [<a href="#rid38">38</a>]. Prevalence of supraventricular and ventricular ectopic activity on 24-hour Holter ambulatory monitoring was similar in the symptomatic and control groups. </p><p>Only 10 percent of symptomatic episodes were accompanied by the presence of an arrhythmia [<a href="#rid38">38</a>]. A sensation of palpitations during pregnancy in the absence of concomitant cardiac arrhythmias may be related to the high output state, including increased heart rate, decreased peripheral resistance, and increased stroke volumes. (See  <a class="medical medical_review" href="/d/html/443.html" rel="external">"Maternal adaptations to pregnancy: Cardiovascular and hemodynamic changes"</a>.)</p><p class="headingAnchor" id="H18809374"><span class="h1">PREMATURE VENTRICULAR COMPLEX/CONTRACTION</span><span class="headingEndMark"> — </span>Premature ventricular complex/contraction (PVC; also referred to a premature ventricular beats or premature ventricular depolarizations) is frequently detected in pregnant women. The prevalence is dependent upon the duration of observation and the clinical presentation. (See  <a class="medical medical_review" href="/d/html/994.html" rel="external">"Premature ventricular complexes: Clinical presentation and diagnostic evaluation"</a>.) </p><p>In the above referenced study of 110 symptomatic and 52 asymptomatic pregnant women, the prevalence of isolated PVCs was similar in symptomatic and asymptomatic women (49 versus 40 percent) [<a href="#rid38">38</a>]. However, frequent PVCs (≥50 PVCs per 24 hours) were more common in symptomatic women (22 versus 4 percent). There was a significant reduction in the frequency of combined atrial and ventricular ectopic activity in the nine women in whom Holter monitoring was repeated postpartum.</p><p class="headingAnchor" id="H18809382"><span class="h2">Clinical presentation</span><span class="headingEndMark"> — </span>PVCs produce few or no symptoms in the majority of women, although some women may experience symptoms of palpitations or dizziness. (See  <a class="medical medical_review" href="/d/html/994.html" rel="external">"Premature ventricular complexes: Clinical presentation and diagnostic evaluation", section on 'Clinical presentation and ECG findings'</a>.)</p><p class="headingAnchor" id="H18809390"><span class="h2">Management during pregnancy</span><span class="headingEndMark"> — </span>The management of PVCs in pregnancy is discussed separately. (See  <a class="medical medical_review" href="/d/html/122361.html" rel="external">"Premature ventricular complexes: Treatment and prognosis", section on 'Pregnancy'</a>.)</p><p class="headingAnchor" id="H18809398"><span class="h1">VENTRICULAR TACHYARRHYTHMIAS</span><span class="headingEndMark"> — </span>Ventricular tachyarrhythmias (ventricular tachycardia [VT] or ventricular fibrillation [VF]) are rare during pregnancy [<a href="#rid39">39</a>]. The management of ventricular arrhythmias needs to be tailored to the individual. The following are among the clinical factors that should be considered:</p><p class="bulletIndent1"><span class="glyph">●</span>Etiology of the VT (catecholamine sensitive versus noncatecholamine sensitive)</p><p class="bulletIndent1"><span class="glyph">●</span>Frequency and duration of VT (nonsustained versus sustained)</p><p class="bulletIndent1"><span class="glyph">●</span>Severity of associated symptoms</p><p class="bulletIndent1"><span class="glyph">●</span>Presence and severity of underlying heart disease</p><p class="bulletIndent1"><span class="glyph">●</span>Ventricular function</p><p></p><p class="headingAnchor" id="H2050183216"><span class="h2">Causes</span><span class="headingEndMark"> — </span>VT can be seen in pregnant women without apparent structural heart disease [<a href="#rid40">40-42</a>] but is often associated with structural heart disease. The risk of recurrent VT during pregnancy is particularly high (27 percent) in women with structural heart disease and a history of VT [<a href="#rid7">7</a>]. Types of cardiac disease associated with VT in pregnancy include:</p><p class="bulletIndent1"><span class="glyph">●</span>Hypertrophic cardiomyopathy (HCM) [<a href="#rid1">1,7,43,44</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Peripartum cardiomyopathy [<a href="#rid45">45,46</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Arrhythmogenic right ventricular cardiomyopathy [<a href="#rid47">47-52</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Congenital heart disease [<a href="#rid1">1,7,53-55</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Valvular heart disease [<a href="#rid1">1</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Primary electrical disease (eg, long QT syndrome [LQTS] [<a href="#rid56">56,57</a>], Brugada syndrome [<a href="#rid58">58</a>], catecholaminergic polymorphic VT [CPVT] [<a href="#rid59">59</a>], etc) </p><p></p><p>Myocardial infarction with or without coronary artery disease has been observed during pregnancy [<a href="#rid60">60-65</a>] and may be complicated by VT or VF [<a href="#rid63">63,64</a>]. Women with primary electrical diseases are also at risk of VT. Other medical conditions associated with VT during pregnancy are hypomagnesemia [<a href="#rid66">66-68</a>], hypertensive crises [<a href="#rid69">69,70</a>], and thyrotoxicosis [<a href="#rid71">71</a>]. (See  <a class="medical medical_review" href="/d/html/846.html" rel="external">"Significance of hypomagnesemia in cardiovascular disease"</a> and  <a class="medical medical_review" href="/d/html/6805.html" rel="external">"Gestational hypertension"</a> and  <a class="medical medical_review" href="/d/html/7851.html" rel="external">"Overview of thyroid disease and pregnancy"</a> and  <a class="medical medical_review" href="/d/html/7853.html" rel="external">"Cardiovascular effects of hyperthyroidism"</a>.)</p><p class="headingAnchor" id="H18809414"><span class="h2">Idiopathic VT</span><span class="headingEndMark"> — </span>Monomorphic VT without apparent structural heart disease is considered idiopathic. The most common type of idiopathic VT is repetitive monomorphic VT, which usually originates from the right ventricular outflow tract (ECG "signature": left bundle branch block and inferior axis) or, less often, from the left ventricular outflow tract (ECG pattern: right bundle branch block and inferior axis <strong>or</strong> left bundle and inferior axis but earlier precordial transition than for right ventricular outflow tract tachycardia). Another type is idiopathic left VT, which originates from the inferior aspect of the midseptum and has the morphologic pattern of right bundle branch block with left axis deviation (QRS axis around -60°). (See  <a class="medical medical_review" href="/d/html/965.html" rel="external">"Ventricular tachycardia in the absence of apparent structural heart disease"</a> and  <a class="medical medical_review" href="/d/html/933.html" rel="external">"Nonsustained VT in the absence of apparent structural heart disease"</a>.)</p><p>A study of seven women presenting with new-onset idiopathic VT during pregnancy found that the VT was often catecholamine sensitive and that the VT was often suppressed in women who received beta blockers [<a href="#rid41">41</a>]. There were no maternal or fetal complications in this series. There is one case report of sudden death in a woman with idiopathic VT who died in the third trimester, three weeks after initiation of <a class="drug drug_general" data-topicid="9813" href="/d/drug information/9813.html" rel="external">procainamide</a> therapy [<a href="#rid72">72</a>].</p><p class="headingAnchor" id="H18809422"><span class="h3">Management during pregnancy</span><span class="headingEndMark"> — </span>Idiopathic VT rarely degenerates into an unstable rhythm and usually has a benign prognosis [<a href="#rid41">41,73</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>Treatment of repetitive monomorphic VT with cardioselective beta blockers may be effective in pregnant women with idiopathic VT even in the absence of a clear relationship to adrenergic tone [<a href="#rid41">41,73-77</a>]. <a class="drug drug_general" data-topicid="9941" href="/d/drug information/9941.html" rel="external">Sotalol</a> can be used as an alternative. (See  <a class="medical medical_review" href="/d/html/965.html" rel="external">"Ventricular tachycardia in the absence of apparent structural heart disease", section on 'Treatment of RMVT'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The less common idiopathic left VT appears to respond well to <a class="drug drug_general" data-topicid="10043" href="/d/drug information/10043.html" rel="external">verapamil</a>, both for the termination of acute episodes and the prevention of recurrences [<a href="#rid78">78,79</a>]. (See  <a class="medical medical_review" href="/d/html/965.html" rel="external">"Ventricular tachycardia in the absence of apparent structural heart disease", section on 'Treatment of ILVT'</a>.)</p><p></p><p class="headingAnchor" id="H18809430"><span class="h2">Long QT syndrome</span><span class="headingEndMark"> — </span>Although VT during pregnancy has been reported in women with LQTS [<a href="#rid80">80</a>], the increase in heart rate seen during pregnancy may serve to shorten the QT interval and therefore may be partially protective. In women with LQTS, the risk of VT is especially high in the postpartum period [<a href="#rid57">57</a>]. Increased risk of VT during the postpartum period may be related to a decrease in the heart rate and an associated increase in the QT interval. The physiologic stress and altered sleep patterns associated with caring for a newborn infant may also contribute to an increase in adrenergically mediated cardiac events. </p><p>The effect of pregnancy was evaluated in a retrospective analysis of 422 women (111 probands and 311 first-degree relatives) entered into the International LQTS registry [<a href="#rid57">57</a>]. Most of the probands had a personal history of syncope or aborted cardiac arrest. The following findings were noted:</p><p class="bulletIndent1"><span class="glyph">●</span>Probands were significantly more likely to have cardiac events (syncope, aborted cardiac arrest, or sudden cardiac death) in the 40-week postpartum interval than during the prepregnancy period of 40 weeks (23.4 versus 3.8 percent). The increase in risk was distributed throughout the postpartum period. The incidence of first cardiac events during pregnancy was slightly but not significantly increased compared with the prepregnancy period (9.0 versus 3.8 percent).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The postpartum increase in risk also applied to first cardiac events (9.0 versus 1.8 and 0 percent during and before pregnancy).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Treatment with beta blockers was independently associated with a decrease in risk for cardiac events in probands during all three intervals (odds ratio 0.023).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The average probability of having a cardiac event during the postpartum period in probands was 2 percent (1 in 50 pregnancies). Treatment with a beta blocker lowered the risk to 1 in 2500 pregnancies.</p><p></p><p>The risks associated with pregnancy may be different among various LQTS genotypes (see  <a class="medical medical_review" href="/d/html/1036.html" rel="external">"Congenital long QT syndrome: Epidemiology and clinical manifestations", section on 'Influence of genotype on triggers'</a>). The influence of genotype is illustrated by the following observations:</p><p class="bulletIndent1"><span class="glyph">●</span>In a series of 388 LQTS patients referred for genetic testing, postpartum cardiac events were more commonly reported in patients with LQT2 mutation (13 of 80, 16 percent) than in patients with LQT1 (1 of 103, &lt;1 percent). [<a href="#rid81">81</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a series limited to women with a single LQT1 mutation, cardiac event rates associated with pregnancy were low (2.6 percent) [<a href="#rid82">82</a>]. These events occurred only in women with a prior history of symptoms who were not taking beta blockers.</p><p></p><p class="headingAnchor" id="H18809438"><span class="h3">Management during pregnancy</span><span class="headingEndMark"> — </span>We agree with the 2023 HRS expert consensus statement on the management of arrhythmias during pregnancy, the 2017 American College of Cardiology/American Heart Association/Heart Rhythm Society guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death and the 2018 European Society of Cardiology guidelines on the management of cardiovascular diseases during pregnancy. The guidelines recommended that pregnant women with LQTS who have had symptoms benefit from continued beta blocker therapy throughout pregnancy and postpartum, unless there are definite contraindications [<a href="#rid18">18,83</a>].</p><p class="headingAnchor" id="H352691465"><span class="h2">Brugada syndrome</span><span class="headingEndMark"> — </span>There are limited reports of pregnancies in women with Brugada syndrome. In one retrospective single-center study including 104 women (219 deliveries) with Brugada syndrome, six women (6 percent) experienced recurrent syncope during pregnancy [<a href="#rid84">84</a>]. Five women continued to experience syncope after delivery and four women received an implantable cardioverter-defibrillator (ICD), as syncope is regarded a high-risk feature for ventricular arrhythmias. No serious events were reported during the peripartum period. In three women with Brugada syndrome and an ICD, no noteworthy problems were reported during pregnancy. There is one case report of electrical storm during pregnancy [<a href="#rid58">58</a>]. The use of low-dose <a class="drug drug_general" data-topicid="8578" href="/d/drug information/8578.html" rel="external">isoproterenol</a> infusion followed by oral <a class="drug drug_general" data-topicid="9846" href="/d/drug information/9846.html" rel="external">quinidine</a> has been used to treat VT and normalize the ECG [<a href="#rid58">58</a>]. (See  <a class="medical medical_review" href="/d/html/106760.html" rel="external">"Brugada syndrome or pattern: Management and approach to screening of relatives", section on 'High-risk patients'</a>.)</p><p class="headingAnchor" id="H2608986552"><span class="h2">Catecholaminergic polymorphic ventricular tachycardia</span><span class="headingEndMark"> — </span>One retrospective study from the Netherlands and Canada evaluated the outcome of pregnancy in 96 women with CPVT who had 228 pregnancies [<a href="#rid59">59</a>]. Most patients (82 percent) had pregnancies before CPVT diagnosis (median age at CPVT diagnosis 40.7 years). Pregnancy and postpartum cardiac events included syncope (5 percent) and an aborted cardiac arrest (1 percent), which occurred in women who were not taking beta blockers. The combined pregnancy and postpartum arrhythmic risk (2.14 events per 100 patient-years) was not elevated compared with the nonpregnant period (1.46 events per 100 patient-years) [<a href="#rid59">59</a>]. </p><p>Beta blockers should be considered a mainstay of medical management in patients with CPVT. In a study of 228 pregnancies in females with CPVT, most of the events occurred in patients not taking beta blockers [<a href="#rid59">59</a>]. </p><p class="headingAnchor" id="H18807931"><span class="h2">VT in women with structural heart disease</span><span class="headingEndMark"> — </span>A large prospective multicenter study in women with heart disease reported four cases of sustained VT in 1315 pregnancies [<a href="#rid85">85</a>].</p><p class="headingAnchor" id="H2770723013"><span class="h3">Causes</span></p><p class="headingAnchor" id="H18809446"><span class="h4">Hypertrophic cardiomyopathy</span><span class="headingEndMark"> — </span>In general, women with HCM tolerate pregnancy well [<a href="#rid44">44,86</a>], although several case reports have described cardiac complications and sudden death during pregnancy [<a href="#rid43">43,44,87-89</a>]. (See  <a class="medical medical_review" href="/d/html/4920.html" rel="external">"Hypertrophic cardiomyopathy: Management of patients with outflow tract obstruction", section on 'Pregnancy'</a>.)</p><p>The largest study investigating mortality and morbidity in pregnant women with HCM included 100 women who had a total of 199 live births [<a href="#rid44">44</a>]. Two sudden cardiac deaths occurred during pregnancy in women with high-risk features. One of the women had severe left ventricular hypertrophy (30 mm maximal wall thickness) and a resting outflow gradient of 115 mmHg. She died suddenly four days after delivery after complaining of palpitations. The other woman had a family history of eight deaths in young relatives, five of which were sudden. This patient developed recurrent episodes of sustained VT during labor. The ROPAC registry examined outcomes in 60 pregnancies and reported a high prevalence of ventricular tachyarrhythmias (10 percent, 6 of 60 patients) [<a href="#rid90">90</a>]. Two of six patients with VT were known to have heart failure, and most cases occurred in the third trimester. </p><p>Management of pregnancy and delivery in women with HCM is discussed separately. (See  <a class="medical medical_review" href="/d/html/4920.html" rel="external">"Hypertrophic cardiomyopathy: Management of patients with outflow tract obstruction", section on 'Pregnancy'</a>.)</p><p class="headingAnchor" id="H18809454"><span class="h4">Congenital heart disease</span><span class="headingEndMark"> — </span>The prevalence of sustained VT during pregnancy in women with congenital heart disease (CHD) has been reported to range from 4.5 to 15.9 per 1000 pregnancies [<a href="#rid1">1,53</a>] (see  <a class="medical medical_review" href="/d/html/1422.html" rel="external">"Pregnancy in women with congenital heart disease: General principles"</a> and  <a class="medical medical_review" href="/d/html/1415.html" rel="external">"Pregnancy in women with congenital heart disease: Specific lesions"</a>). Prevalence rates are strongly influenced by the types of cardiac lesions in the study population.</p><p class="bulletIndent1"><span class="glyph">●</span>In a prospective multicenter study in women with CHD, two cases of sustained VT occurred in 445 pregnancies. One woman had an unrepaired intracardiac shunt and the other had repaired congenital aortic stenosis [<a href="#rid1">1</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A multicenter study from Japan reported two cases of sustained VT during 126 pregnancies [<a href="#rid53">53</a>]. Both cases of VT occurred in women with repaired tetralogy of Fallot and both were successfully treated with intravenous <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a>. Seven pregnancies were complicated by nonsustained VT, none of which were treated.</p><p></p><p class="headingAnchor" id="H18809462"><span class="h4">Peripartum cardiomyopathy</span><span class="headingEndMark"> — </span>Peripartum cardiomyopathy is a rare and sometimes life-threatening condition defined as development of systolic heart failure in the last month of pregnancy or within five months of delivery. The incidence varies widely among various populations. The clinical presentation includes symptoms of new-onset heart failure such as dyspnea, cough, orthopnea, and hemoptysis. A large retrospective study of 9841 hospitalizations for women with peripartum cardiomyopathy demonstrated a prevalence of VT of 4.2 percent [<a href="#rid91">91</a>]. These ventricular arrhythmias can be refractory to pharmacologic treatment (eg, <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a>, <a class="drug drug_general" data-topicid="9645" href="/d/drug information/9645.html" rel="external">metoprolol</a>, <a class="drug drug_general" data-topicid="8595" href="/d/drug information/8595.html" rel="external">amiodarone</a>) and direct current cardioversion [<a href="#rid45">45,46,92</a>]. (See  <a class="medical medical_review" href="/d/html/4945.html" rel="external">"Peripartum cardiomyopathy: Etiology, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H352691499"><span class="h4">Arrhythmogenic right ventricular cardiomyopathy</span><span class="headingEndMark"> — </span>Most pregnancies in women with arrhythmogenic right ventricular cardiomyopathy are tolerated well [<a href="#rid47">47-52,93</a>]. Pregnancies were managed successfully by close monitoring and antiarrhythmic drugs when necessary. </p><p class="bulletIndent1"><span class="glyph">●</span>Data from the combined Johns Hopkins/Dutch ARVD/C registry provided information on 26 women during 39 pregnancies (&gt;13 weeks) [<a href="#rid94">94</a>]. A single episode of sustained ventricular arrhythmia complicated five pregnancies (13 percent) of five women without a prior history of sustained ventricular arrhythmias. Interruption of beta blockers was associated with two of these events. Previous studies have shown that withdrawal of beta blockers during pregnancy may exacerbate the occurrence of VT during pregnancy [<a href="#rid49">49,52</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Among a cohort of 120 Chinese women with 224 pregnancies between 1995 and 2018, adverse cardiac events were reported in only 12 pregnancies (5.4 percent), with only two episodes of syncope and one episode of sustained VT [<a href="#rid93">93</a>]. Eight of the 12 reported adverse events related to the development of, or increase in, PVC frequency. </p><p></p><p class="headingAnchor" id="H18807997"><span class="h3">Management of VT during pregnancy in women with structural heart disease</span></p><p class="headingAnchor" id="H18809470"><span class="h4">Management of acute episodes</span><span class="headingEndMark"> — </span>Acute treatment of sustained ventricular arrhythmias in pregnant women is similar to that in nonpregnant women. Ventricular arrhythmias in the presence of structural heart disease are potentially life-threatening and require immediate evaluation for hemodynamic instability to determine whether electrical cardioversion or defibrillation is indicated [<a href="#rid18">18</a>]. </p><p>In hemodynamically well-tolerated VT, pharmacological cardioversion may be acceptable. Pharmacological options include intravenous <a class="drug drug_general" data-topicid="9813" href="/d/drug information/9813.html" rel="external">procainamide</a>, <a class="drug drug_general" data-topicid="8595" href="/d/drug information/8595.html" rel="external">amiodarone</a>, or <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a> [<a href="#rid18">18</a>]; the choice of pharmacological agents should be tailored to the individual case. For women at risk for VT during labor and delivery, it is important to ensure that appropriate cardiac medications and external defibrillators are available in the delivery suites.</p><p class="headingAnchor" id="H18809478"><span class="h4">Electrical cardioversion</span><span class="headingEndMark"> — </span>Urgent or elective electrical cardioversion can be performed at all stages of pregnancy [<a href="#rid14">14,95-101</a>]. Electrical cardioversion is indicated for any sustained VT with hemodynamic compromise [<a href="#rid18">18</a>] and can be considered for drug-refractory VT. Electrical cardioversion does not result in compromise of blood flow to the fetus [<a href="#rid102">102</a>]. While there is a theoretical risk of inducing an arrhythmia in the fetus, this risk is very small due to the high fibrillation threshold and small amount of energy reaching the fetus [<a href="#rid14">14,95,103</a>]. Nonetheless, fetal rhythm monitoring is recommended once viability is reached because of rare reported cases of cardioversion precipitating fetal distress and requiring emergency cesarean delivery [<a href="#rid104">104</a>]. Electrode placement is similar to the nonpregnant patient, but in order to maximize current, placement over breast tissue should be avoided. Shock outputs used should be similar to those recommended in the nonpregnant patient. (See  <a class="medical medical_review" href="/d/html/975.html" rel="external">"Basic principles and technique of external electrical cardioversion and defibrillation"</a> and  <a class="medical medical_review" href="/d/html/983.html" rel="external">"Cardioversion for specific arrhythmias"</a>.)</p><p class="headingAnchor" id="H18809486"><span class="h4">Prophylactic pharmacologic therapy during pregnancy</span><span class="headingEndMark"> — </span>The risk of recurrent VT and sudden death in women with structural heart disease can be substantial and the benefits of prophylactic drug therapy may outweigh the potential fetal adverse effects of these drugs (see  <a class="medical medical_review" href="/d/html/963.html" rel="external">"Overview of sudden cardiac arrest and sudden cardiac death"</a>). The risk of sudden death is further increased when concomitant left ventricular dysfunction is present.</p><p>Depending on the underlying cardiac condition, beta-1 selective beta blockers alone, antiarrhythmic drugs alone, or both in combination can be effective [<a href="#rid17">17,18</a>]. Gestational exposure to <a class="drug drug_general" data-topicid="8595" href="/d/drug information/8595.html" rel="external">amiodarone</a> is associated with neonatal hypothyroidism and hyperthyroidism. Small-for-gestational-age infants are reported with gestational exposure to the combination of amiodarone and beta blockers [<a href="#rid105">105</a>]. In some cases, <a class="drug drug_general" data-topicid="9941" href="/d/drug information/9941.html" rel="external">sotalol</a> can be considered if beta-blocker therapy is ineffective. Because of potential fetal side effects, all women should be counseled about the potential risks and benefits of drug therapy. (See  <a class="medical medical_review" href="/d/html/931.html" rel="external">"Amiodarone: Adverse effects, potential toxicities, and approach to monitoring"</a> and  <a class="medical medical_review" href="/d/html/926.html" rel="external">"Amiodarone: Clinical uses"</a>.)</p><p>Although some have used class IA (eg, <a class="drug drug_general" data-topicid="9846" href="/d/drug information/9846.html" rel="external">quinidine</a>, <a class="drug drug_general" data-topicid="9813" href="/d/drug information/9813.html" rel="external">procainamide</a>) or IC (eg, <a class="drug drug_general" data-topicid="8449" href="/d/drug information/8449.html" rel="external">flecainide</a>) drugs as prophylactic treatment for VT during pregnancy [<a href="#rid106">106,107</a>], these drugs are not generally recommended since they have <strong>not</strong> improved survival in the nonpregnant population with structural heart disease, presumably because of proarrhythmic effects [<a href="#rid108">108</a>]. </p><p class="headingAnchor" id="H18809494"><span class="h4">Implantable cardioverter-defibrillator</span><span class="headingEndMark"> — </span>Women with an implantable cardioverter-defibrillator (ICD) can have a successful pregnancy with good fetal outcome [<a href="#rid109">109-111</a>]. Indications for ICD placement are discussed separately, but in general, pregnant women who have an indication for ICD should have the ICD implanted using strategies to minimize radiation during the procedure. (See  <a class="medical medical_review" href="/d/html/946.html" rel="external">"Secondary prevention of sudden cardiac death in heart failure and cardiomyopathy"</a>.)</p><p>In a retrospective multicenter study of pregnancy outcomes in women with ICDs (n = 44), 25 percent (11 of 44) of the pregnancies were complicated by at least one shock [<a href="#rid109">109</a>]. All ICDs were implanted for secondary prevention and the underlying cardiac diseases were primary electrical diseases (ie, LQTS, idiopathic VF) or structural heart diseases (ie, cardiomyopathy, congenital heart disease, arrhythmogenic right ventricular cardiomyopathy). Pregnancy was not associated with an increase in ICD-related complications or an increase in the number of shocks (0.07 versus 0.06 shocks per month) compared with the preconception period [<a href="#rid109">109</a>].</p><p>The experience with ICD implantation during pregnancy is limited [<a href="#rid112">112</a>]; however, pacemaker implantation during pregnancy can be accomplished and total radiation dose can be reduced by using echocardiographic guidance [<a href="#rid113">113,114</a>]. </p><p>Subcutaneous ICDs are being increasingly used, but studies pertaining to implantation and management during pregnancy are lacking.</p><p>For some women with potentially reversible risk factors for sudden death (eg, women with peripartum cardiomyopathy in whom ventricular function may improve), an external wearable automatic defibrillator (LifeVest) can be considered during pregnancy or early postpartum. </p><p class="headingAnchor" id="H18809502"><span class="h4">Radiofrequency catheter ablation</span><span class="headingEndMark"> — </span>The success rate of radiofrequency catheter ablation of monomorphic VT is between 80 to 100 percent [<a href="#rid115">115-119</a>] and may be considered in women who are using antiarrhythmic therapy and are contemplating pregnancy (see  <a class="medical medical_review" href="/d/html/1007.html" rel="external">"Overview of catheter ablation of cardiac arrhythmias"</a>). Currently, there is only limited experience with catheter ablation of VT during pregnancy [<a href="#rid17">17,120,121</a>].</p><p>Most experience with radiofrequency catheter ablation during pregnancy has been for cases of supraventricular tachycardia [<a href="#rid121">121-129</a>]. These procedures are generally not performed during pregnancy, mainly due to concerns of ionizing radiation exposure to the fetus. However, in rare cases, women with severe and drug-resistant VT during pregnancy may be considered for an ablation procedure. The risk of radiation exposure for the fetus during a typical ablation is small (&lt;1 mGy at all periods of gestation) and is mainly attributable to scatter from the thorax of the mother [<a href="#rid130">130</a>]. Ablation using intracardiac echocardiography and electroanatomic mapping without fluoroscopy may be an alternative. (See  <a class="medical medical_review" href="/d/html/4791.html" rel="external">"Diagnostic imaging in pregnant and lactating patients", section on 'Fetal risks'</a>.)</p><p class="headingAnchor" id="H1743296714"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/112260.html" rel="external">"Society guideline links: Arrhythmias in adults"</a> and  <a class="medical medical_society_guidelines" href="/d/html/115586.html" rel="external">"Society guideline links: Ventricular arrhythmias"</a>.) </p><p class="headingAnchor" id="H1633095"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>General approach </strong>– Ventricular tachyarrhythmias are frequently associated with acquired or structural heart disease and therefore any woman who presents with a ventricular arrhythmia during pregnancy should undergo clinical evaluation for structural heart disease (including an ECG and a transthoracic echocardiogram). Due to surgical advances, the number of women of childbearing age with congenital heart disease has increased and this group of women is at particularly high risk for arrhythmias  (<a class="graphic graphic_figure graphicRef61986" href="/d/graphic/61986.html" rel="external">figure 1</a>)</p><p></p><p class="bulletIndent1">Information on the use of specific antiarrhythmic drugs in pregnancy, including the US Food and Drug Administration risk category and pregnancy implications, is available in the UpToDate drug database. (See <a class="local">'General approach'</a> above and <a class="local">'VT in women with structural heart disease'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Idiopathic VT </strong>– Monomorphic ventricular tachycardia (VT) without apparent structural heart disease is considered idiopathic. The most common type originates from the right ventricular outflow tract, and this form of VT can often be successfully treated with beta blockers or <a class="drug drug_general" data-topicid="10043" href="/d/drug information/10043.html" rel="external">verapamil</a>. (See <a class="local">'Idiopathic VT'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Long QT syndrome </strong>– Women with the long QT syndrome are at risk for VT, especially in the postpartum period. Pregnant women with long QT syndrome should be treated with beta blocker therapy throughout pregnancy and postpartum. (See <a class="local">'Long QT syndrome'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management of acute episodes </strong>– Acute treatment of sustained ventricular arrhythmias in pregnant women is similar to that in nonpregnant women. Ventricular arrhythmias in the presence of structural heart disease are potentially life-threatening and require immediate evaluation for hemodynamic instability to determine whether electrical cardioversion or defibrillation is indicated. (See <a class="local">'Management of acute episodes'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prophylactic pharmacologic therapy during pregnancy </strong>– In women with structural heart disease and a history of VT, the benefits of prophylactic drug therapy may outweigh the potential fetal adverse effects of these drugs.  (<a class="graphic graphic_table graphicRef50716" href="/d/graphic/50716.html" rel="external">table 1</a>) (See <a class="local">'Prophylactic pharmacologic therapy during pregnancy'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Implantable cardioverter-defibrillator </strong>– Women with an implantable cardioverter-defibrillator can have a successful pregnancy with good fetal outcome. (See <a class="local">'Implantable cardioverter-defibrillator'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001; 104:515.</a></li><li><a class="nounderline abstract_t">Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol 2007; 49:2303.</a></li><li><a class="nounderline abstract_t">Drenthen W, Boersma E, Balci A, et al. Predictors of pregnancy complications in women with congenital heart disease. Eur Heart J 2010; 31:2124.</a></li><li><a class="nounderline abstract_t">Vaidya VR, Arora S, Patel N, et al. Burden of Arrhythmia in Pregnancy. Circulation 2017; 135:619.</a></li><li><a class="nounderline abstract_t">Lee SH, Chen SA, Wu TJ, et al. Effects of pregnancy on first onset and symptoms of paroxysmal supraventricular tachycardia. Am J Cardiol 1995; 76:675.</a></li><li><a class="nounderline abstract_t">Doig JC, McComb JM, Reid DS. Incessant atrial tachycardia accelerated by pregnancy. Br Heart J 1992; 67:266.</a></li><li><a class="nounderline abstract_t">Silversides CK, Harris L, Haberer K, et al. Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes. Am J Cardiol 2006; 97:1206.</a></li><li><a class="nounderline abstract_t">Siu SC, Sermer M, Harrison DA, et al. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation 1997; 96:2789.</a></li><li><a class="nounderline abstract_t">Drenthen W, Pieper PG, Ploeg M, et al. Risk of complications during pregnancy after Senning or Mustard (atrial) repair of complete transposition of the great arteries. Eur Heart J 2005; 26:2588.</a></li><li><a class="nounderline abstract_t">Drenthen W, Pieper PG, van der Tuuk K, et al. Cardiac complications relating to pregnancy and recurrence of disease in the offspring of women with atrioventricular septal defects. Eur Heart J 2005; 26:2581.</a></li><li><a class="nounderline abstract_t">Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Pregnancy and delivery in women after Fontan palliation. Heart 2006; 92:1290.</a></li><li><a class="nounderline abstract_t">Blomström-Lundqvist C, Scheinman MM, Aliot EM, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Circulation 2003; 108:1871.</a></li><li><a class="nounderline abstract_t">Joglar JA, Page RL. Treatment of cardiac arrhythmias during pregnancy: safety considerations. Drug Saf 1999; 20:85.</a></li><li><a class="nounderline abstract_t">Cox JL, Gardner MJ. Treatment of cardiac arrhythmias during pregnancy. Prog Cardiovasc Dis 1993; 36:137.</a></li><li><a class="nounderline abstract_t">Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Kardiol Pol 2019; 77:245.</a></li><li><a class="nounderline abstract_t">Joglar JA, Kapa S, Saarel EV, et al. 2023 HRS expert consensus statement on the management of arrhythmias during pregnancy. Heart Rhythm 2023; 20:e175.</a></li><li><a class="nounderline abstract_t">Halpern DG, Weinberg CR, Pinnelas R, et al. Use of Medication for Cardiovascular Disease During Pregnancy: JACC State-of-the-Art Review. J Am Coll Cardiol 2019; 73:457.</a></li><li><a class="nounderline abstract_t">Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018; 39:3165.</a></li><li><a class="nounderline abstract_t">Sanghavi M, Rutherford JD. Cardiovascular physiology of pregnancy. Circulation 2014; 130:1003.</a></li><li class="breakAll">Silversides CK, Colman JM. Physiological changes in pregnancy. In: Heart disease in pregnancy, 2nd ed, Oakley C, Warnes CA (Eds), Blackwell Publishing, Malden 2007. p.6.</li><li class="breakAll">Elkayam U, Gleicher N. Hemodynamics and cardiac function during normal pregnancy and puerperium. In: Cardiac problems in pregnancy, 3rd ed, Elkayam U, Gleicher N (Eds), Wiley-Liss, New York 1998. p.3.</li><li><a class="nounderline abstract_t">Katz R, Karliner JS, Resnik R. Effects of a natural volume overload state (pregnancy) on left ventricular performance in normal human subjects. Circulation 1978; 58:434.</a></li><li><a class="nounderline abstract_t">Rubler S, Damani PM, Pinto ER. Cardiac size and performance during pregnancy estimated with echocardiography. Am J Cardiol 1977; 40:534.</a></li><li><a class="nounderline abstract_t">Liebson PR, Mann LI, Evans MI, et al. Cardiac performance during pregnancy: serial evaluation using external systolic time intervals. Am J Obstet Gynecol 1975; 122:1.</a></li><li><a class="nounderline abstract_t">Campos O. Doppler Echocardiography During Pregnancy: Physiological and Abnormal Findings. Echocardiography 1996; 13:135.</a></li><li><a class="nounderline abstract_t">Franz MR, Cima R, Wang D, et al. Electrophysiological effects of myocardial stretch and mechanical determinants of stretch-activated arrhythmias. Circulation 1992; 86:968.</a></li><li><a class="nounderline abstract_t">Wang Y, Joyner RW, Wagner MB, et al. Stretch-activated channel activation promotes early afterdepolarizations in rat ventricular myocytes under oxidative stress. Am J Physiol Heart Circ Physiol 2009; 296:H1227.</a></li><li><a class="nounderline abstract_t">Ninio DM, Saint DA. The role of stretch-activated channels in atrial fibrillation and the impact of intracellular acidosis. Prog Biophys Mol Biol 2008; 97:401.</a></li><li><a class="nounderline abstract_t">Kamkin A, Kiseleva I, Isenberg G. Stretch-activated currents in ventricular myocytes: amplitude and arrhythmogenic effects increase with hypertrophy. Cardiovasc Res 2000; 48:409.</a></li><li><a class="nounderline abstract_t">Soliman EZ, Elsalam MA, Li Y. The relationship between high resting heart rate and ventricular arrhythmogenesis in patients referred to ambulatory 24 h electrocardiographic recording. Europace 2010; 12:261.</a></li><li><a class="nounderline abstract_t">Zuspan FP. Catecholamines. Their role in pregnancy and the development of pregnancy-induced hypertension. J Reprod Med 1979; 23:143.</a></li><li><a class="nounderline abstract_t">Natrajan PG, McGarrigle HH, Lawrence DM, Lachelin GC. Plasma noradrenaline and adrenaline levels in normal pregnancy and in pregnancy-induced hypertension. Br J Obstet Gynaecol 1982; 89:1041.</a></li><li><a class="nounderline abstract_t">Whittaker PG, Gerrard J, Lind T. Catecholamine responses to changes in posture during human pregnancy. Br J Obstet Gynaecol 1985; 92:586.</a></li><li><a class="nounderline abstract_t">Barron WM, Mujais SK, Zinaman M, et al. Plasma catecholamine responses to physiologic stimuli in normal human pregnancy. Am J Obstet Gynecol 1986; 154:80.</a></li><li><a class="nounderline abstract_t">Ramsay MM, Broughton Pipkin F, Rubin PC. Pressor, heart rate and plasma catecholamine responses to noradrenaline in pregnant and nonpregnant women. Br J Obstet Gynaecol 1993; 100:170.</a></li><li><a class="nounderline abstract_t">Roberts JM, Insel PA, Goldfien A. Regulation of myometrial adrenoreceptors and adrenergic response by sex steroids. Mol Pharmacol 1981; 20:52.</a></li><li><a class="nounderline abstract_t">Priori SG, Mantica M, Schwartz PJ. Delayed afterdepolarizations elicited in vivo by left stellate ganglion stimulation. Circulation 1988; 78:178.</a></li><li><a class="nounderline abstract_t">Shotan A, Ostrzega E, Mehra A, et al. Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope. Am J Cardiol 1997; 79:1061.</a></li><li><a class="nounderline abstract_t">Li JM, Nguyen C, Joglar JA, et al. Frequency and outcome of arrhythmias complicating admission during pregnancy: experience from a high-volume and ethnically-diverse obstetric service. Clin Cardiol 2008; 31:538.</a></li><li><a class="nounderline abstract_t">PINE HL, FOX L, SHOOK DM. PAROXYSMAL VENTRICULAR TACHYCARDIA COMPLICATING PREGNANCY. Am J Cardiol 1965; 15:732.</a></li><li><a class="nounderline abstract_t">Brodsky M, Doria R, Allen B, et al. New-onset ventricular tachycardia during pregnancy. Am Heart J 1992; 123:933.</a></li><li><a class="nounderline abstract_t">Braverman AC, Bromley BS, Rutherford JD. New onset ventricular tachycardia during pregnancy. Int J Cardiol 1991; 33:409.</a></li><li><a class="nounderline abstract_t">Shah DM, Sunderji SG. Hypertrophic cardiomyopathy and pregnancy: report of a maternal mortality and review of literature. Obstet Gynecol Surv 1985; 40:444.</a></li><li><a class="nounderline abstract_t">Autore C, Conte MR, Piccininno M, et al. Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol 2002; 40:1864.</a></li><li><a class="nounderline abstract_t">Gemici G, Tezcan H, Fak AS, Oktay A. Peripartum cardiomyopathy presenting with repetitive monomorphic ventricular tachycardia. Pacing Clin Electrophysiol 2004; 27:557.</a></li><li><a class="nounderline abstract_t">Puri A, Sethi R, Singh B, et al. Peripartum cardiomyopathy presenting with ventricular tachycardia: a rare presentation. Indian Pacing Electrophysiol J 2009; 9:186.</a></li><li><a class="nounderline abstract_t">Bauce B, Daliento L, Frigo G, et al. Pregnancy in women with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Eur J Obstet Gynecol Reprod Biol 2006; 127:186.</a></li><li><a class="nounderline abstract_t">Agir A, Bozyel S, Celikyurt U, et al. Arrhythmogenic right ventricular cardiomyopathy in pregnancy. Int Heart J 2014; 55:372.</a></li><li><a class="nounderline abstract_t">Iriyama T, Kamei Y, Kozuma S, Taketani Y. Management of patient with arrhythmogenic right ventricular cardiomyopathy during pregnancy. J Obstet Gynaecol Res 2013; 39:390.</a></li><li><a class="nounderline abstract_t">Doyle NM, Monga M, Montgomery B, Dougherty AH. Arrhythmogenic right ventricular cardiomyopathy with implantable cardioverter defibrillator placement in pregnancy. J Matern Fetal Neonatal Med 2005; 18:141.</a></li><li><a class="nounderline abstract_t">Lee LC, Bathgate SL, Macri CJ. Arrhythmogenic right ventricular dysplasia in pregnancy: a case report. J Reprod Med 2006; 51:725.</a></li><li><a class="nounderline abstract_t">Güdücü N, Kutay SS, Ozenç E, et al. Management of a rare case of arrhythmogenic right ventricular dysplasia in pregnancy: a case report. J Med Case Rep 2011; 5:300.</a></li><li><a class="nounderline abstract_t">Tateno S, Niwa K, Nakazawa M, et al. Arrhythmia and conduction disturbances in patients with congenital heart disease during pregnancy: multicenter study. Circ J 2003; 67:992.</a></li><li><a class="nounderline abstract_t">Whittemore R, Hobbins JC, Engle MA. Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease. Am J Cardiol 1982; 50:641.</a></li><li><a class="nounderline abstract_t">Perloff JK. Pregnancy and congenital heart disease. J Am Coll Cardiol 1991; 18:340.</a></li><li><a class="nounderline abstract_t">Roden DM, Lazzara R, Rosen M, et al. Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS. Circulation 1996; 94:1996.</a></li><li><a class="nounderline abstract_t">Rashba EJ, Zareba W, Moss AJ, et al. Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Investigators. Circulation 1998; 97:451.</a></li><li><a class="nounderline abstract_t">Sharif-Kazemi MB, Emkanjoo Z, Tavoosi A, et al. Electrical storm in Brugada syndrome during pregnancy. Pacing Clin Electrophysiol 2011; 34:e18.</a></li><li><a class="nounderline abstract_t">Cheung CC, Lieve KV, Roston TM, et al. Pregnancy in Catecholaminergic Polymorphic Ventricular Tachycardia. JACC Clin Electrophysiol 2019; 5:387.</a></li><li><a class="nounderline abstract_t">Sasse L, Wagner R, Murray FE. Transmural myocardial infarction during pregnancy. Am J Cardiol 1975; 35:448.</a></li><li><a class="nounderline abstract_t">Sperry KL. Myocardial infarction in pregnancy. J Forensic Sci 1987; 32:1464.</a></li><li><a class="nounderline abstract_t">Hankins GD, Wendel GD Jr, Leveno KJ, Stoneham J. Myocardial infarction during pregnancy: a review. Obstet Gynecol 1985; 65:139.</a></li><li><a class="nounderline abstract_t">Curry JJ, Quintana FJ. Myocardial infarction with ventricular fibrillation during pregnancy treated by direct current defibrillation with fetal survival. Chest 1970; 58:82.</a></li><li><a class="nounderline abstract_t">O'Donnell M, Meecham J, Tosson SR, Ward S. Ventricular fibrillation and reinfarction in pregnancy. Postgrad Med J 1987; 63:1095.</a></li><li><a class="nounderline abstract_t">Sonel A, Erol C, Oral D, et al. Acute myocardial infarction and normal coronary arteries in a pregnant woman. Cardiology 1988; 75:218.</a></li><li><a class="nounderline abstract_t">Onagawa T, Ohkuchi A, Ohki R, et al. Woman with postpartum ventricular tachycardia and hypomagnesemia. J Obstet Gynaecol Res 2003; 29:92.</a></li><li><a class="nounderline abstract_t">Varon ME, Sherer DM, Abramowicz JS, Akiyama T. Maternal ventricular tachycardia associated with hypomagnesemia. Am J Obstet Gynecol 1992; 167:1352.</a></li><li><a class="nounderline abstract_t">Mela T, Galvin JM, McGovern BA. Magnesium deficiency during lactation as a precipitant of ventricular tachyarrhythmias. Pacing Clin Electrophysiol 2002; 25:231.</a></li><li><a class="nounderline abstract_t">Naidoo DP, Bhorat I, Moodley J, et al. Continuous electrocardiographic monitoring in hypertensive crises in pregnancy. Am J Obstet Gynecol 1991; 164:530.</a></li><li><a class="nounderline abstract_t">Bhorat IE, Naidoo DP, Rout CC, Moodley J. Malignant ventricular arrhythmias in eclampsia: a comparison of labetalol with dihydralazine. Am J Obstet Gynecol 1993; 168:1292.</a></li><li><a class="nounderline abstract_t">Kinugawa T, Fujimoto Y, Miyakoda H, et al. A case of paroxysmal ventricular tachycardia during pregnancy. Jpn Circ J 1989; 53:807.</a></li><li><a class="nounderline abstract_t">RALLY CR, WALTERS MB. Paroxysmal ventricular tachycardia without evident heart disease. Can Med Assoc J 1962; 86:268.</a></li><li><a class="nounderline abstract_t">Lemery R, Brugada P, Bella PD, et al. Nonischemic ventricular tachycardia. Clinical course and long-term follow-up in patients without clinically overt heart disease. Circulation 1989; 79:990.</a></li><li><a class="nounderline abstract_t">Page RL, Shenasa H, Evans JJ, et al. Radiofrequency catheter ablation of idiopathic recurrent ventricular tachycardia with right bundle branch block, left axis morphology. Pacing Clin Electrophysiol 1993; 16:327.</a></li><li><a class="nounderline abstract_t">Trappe HJ, Brugada P, Talajic M, et al. Prognosis of patients with ventricular tachycardia and ventricular fibrillation: role of the underlying etiology. J Am Coll Cardiol 1988; 12:166.</a></li><li><a class="nounderline abstract_t">Sung RJ, Keung EC, Nguyen NX, Huycke EC. Effects of beta-adrenergic blockade on verapamil-responsive and verapamil-irresponsive sustained ventricular tachycardias. J Clin Invest 1988; 81:688.</a></li><li><a class="nounderline abstract_t">Chandra NC, Gates EA, Thamer M. Conservative treatment of paroxysmal ventricular tachycardia during pregnancy. Clin Cardiol 1991; 14:347.</a></li><li><a class="nounderline abstract_t">Lin FC, Finley CD, Rahimtoola SH, Wu D. Idiopathic paroxysmal ventricular tachycardia with a QRS pattern of right bundle branch block and left axis deviation: a unique clinical entity with specific properties. Am J Cardiol 1983; 52:95.</a></li><li><a class="nounderline abstract_t">Cleary-Goldman J, Salva CR, Infeld JI, Robinson JN. Verapamil-sensitive idiopathic left ventricular tachycardia in pregnancy. J Matern Fetal Neonatal Med 2003; 14:132.</a></li><li><a class="nounderline abstract_t">O'Callaghan AC, Normandale JP, Morgan M. The prolonged Q-T syndrome. A review with anaesthetic implications and a report of two cases. Anaesth Intensive Care 1982; 10:50.</a></li><li><a class="nounderline abstract_t">Khositseth A, Tester DJ, Will ML, et al. Identification of a common genetic substrate underlying postpartum cardiac events in congenital long QT syndrome. Heart Rhythm 2004; 1:60.</a></li><li><a class="nounderline abstract_t">Heradien MJ, Goosen A, Crotti L, et al. Does pregnancy increase cardiac risk for LQT1 patients with the KCNQ1-A341V mutation? J Am Coll Cardiol 2006; 48:1410.</a></li><li><a class="nounderline abstract_t">Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation 2018; 138:e272.</a></li><li><a class="nounderline abstract_t">Rodríguez-Mañero M, Casado-Arroyo R, Sarkozy A, et al. The clinical significance of pregnancy in Brugada syndrome. Rev Esp Cardiol (Engl Ed) 2014; 67:176.</a></li><li><a class="nounderline abstract_t">Pfaller B, Sathananthan G, Grewal J, et al. Preventing Complications in Pregnant Women With Cardiac Disease. J Am Coll Cardiol 2020; 75:1443.</a></li><li><a class="nounderline abstract_t">Oakley GD, McGarry K, Limb DG, Oakley CM. Management of pregnancy in patients with hypertrophic cardiomyopathy. Br Med J 1979; 1:1749.</a></li><li><a class="nounderline abstract_t">Pelliccia F, Cianfrocca C, Gaudio C, Reale A. Sudden death during pregnancy in hypertrophic cardiomyopathy. Eur Heart J 1992; 13:421.</a></li><li><a class="nounderline abstract_t">van Kasteren YM, Kleinhout J, Smit MA, et al. Hypertrophic cardiomyopathy and pregnancy: a report of three cases. Eur J Obstet Gynecol Reprod Biol 1991; 38:63.</a></li><li><a class="nounderline abstract_t">Tanous D, Siu SC, Mason J, et al. B-type natriuretic peptide in pregnant women with heart disease. J Am Coll Cardiol 2010; 56:1247.</a></li><li><a class="nounderline abstract_t">Goland S, van Hagen IM, Elbaz-Greener G, et al. Pregnancy in women with hypertrophic cardiomyopathy: data from the European Society of Cardiology initiated Registry of Pregnancy and Cardiac disease (ROPAC). Eur Heart J 2017; 38:2683.</a></li><li><a class="nounderline abstract_t">Mallikethi-Reddy S, Akintoye E, Trehan N, et al. Burden of arrhythmias in peripartum cardiomyopathy: Analysis of 9841 hospitalizations. Int J Cardiol 2017; 235:114.</a></li><li><a class="nounderline abstract_t">Palma EC, Saxenberg V, Vijayaraman P, et al. Histopathological correlation of ablation lesions guided by noncontact mapping in a patient with peripartum cardiomyopathy and ventricular tachycardia. Pacing Clin Electrophysiol 2001; 24:1812.</a></li><li><a class="nounderline abstract_t">Wu L, Liang E, Fan S, et al. Effect of Pregnancy in Arrhythmogenic Right Ventricular Cardiomyopathy. Am J Cardiol 2020; 125:613.</a></li><li><a class="nounderline abstract_t">Hodes AR, Tichnell C, Te Riele AS, et al. Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy. Heart 2016; 102:303.</a></li><li><a class="nounderline abstract_t">Page RL. Treatment of arrhythmias during pregnancy. Am Heart J 1995; 130:871.</a></li><li><a class="nounderline abstract_t">Ueland K, McAnulty JH, Ueland FR, Metcalfe J. Special considerations in the use of cardiovascular drugs. Clin Obstet Gynecol 1981; 24:809.</a></li><li><a class="nounderline abstract_t">VOGEL JH, PRYOR R, BLOUNT SG Jr. DIRECT-CURRENT DEFIBRILLATION DURING PREGNANCY. JAMA 1965; 193:970.</a></li><li><a class="nounderline abstract_t">Schroeder JS, Harrison DC. Repeated cardioversion during pregnancy. Treatment of refractory paroxysmal atrial tachycardia during 3 successive pregnancies. Am J Cardiol 1971; 27:445.</a></li><li><a class="nounderline abstract_t">Lee RV, Rodgers BD, White LM, Harvey RC. Cardiopulmonary resuscitation of pregnant women. Am J Med 1986; 81:311.</a></li><li><a class="nounderline abstract_t">Hubbard WN, Jenkins BA, Ward DE. Persistent atrial tachycardia in pregnancy. Br Med J (Clin Res Ed) 1983; 287:327.</a></li><li><a class="nounderline abstract_t">Russell RO Jr. Paroxysmal ventricular tachycardia associated with pregnancy. Ala J Med Sci 1969; 6:111.</a></li><li><a class="nounderline abstract_t">Wang YC, Chen CH, Su HY, Yu MH. The impact of maternal cardioversion on fetal haemodynamics. Eur J Obstet Gynecol Reprod Biol 2006; 126:268.</a></li><li><a class="nounderline abstract_t">DeSilva RA, Graboys TB, Podrid PJ, Lown B. Cardioversion and defibrillation. Am Heart J 1980; 100:881.</a></li><li><a class="nounderline abstract_t">Barnes EJ, Eben F, Patterson D. Direct current cardioversion during pregnancy should be performed with facilities available for fetal monitoring and emergency caesarean section. BJOG 2002; 109:1406.</a></li><li><a class="nounderline abstract_t">Magee LA, Downar E, Sermer M, et al. Pregnancy outcome after gestational exposure to amiodarone in Canada. Am J Obstet Gynecol 1995; 172:1307.</a></li><li><a class="nounderline abstract_t">Connaughton M, Jenkins BS. Successful use of flecainide to treat new onset maternal ventricular tachycardia in pregnancy. Br Heart J 1994; 72:297.</a></li><li><a class="nounderline abstract_t">Hill LM, Malkasian GD Jr. The use of quinidine sulfate throughout pregnancy. Obstet Gynecol 1979; 54:366.</a></li><li><a class="nounderline abstract_t">Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321:406.</a></li><li><a class="nounderline abstract_t">Natale A, Davidson T, Geiger MJ, Newby K. Implantable cardioverter-defibrillators and pregnancy: a safe combination? Circulation 1997; 96:2808.</a></li><li><a class="nounderline abstract_t">Piper JM, Berkus M, Ridgway LE 3rd. Pregnancy complicated by chronic cardiomyopathy and an automatic implantable cardioverter defibrillator. Am J Obstet Gynecol 1992; 167:506.</a></li><li><a class="nounderline abstract_t">Miyoshi T, Kamiya CA, Katsuragi S, et al. Safety and efficacy of implantable cardioverter-defibrillator during pregnancy and after delivery. Circ J 2013; 77:1166.</a></li><li><a class="nounderline abstract_t">Abello M, Peinado R, Merino JL, et al. Cardioverter defibrillator implantation in a pregnant woman guided with transesophageal echocardiography. Pacing Clin Electrophysiol 2003; 26:1913.</a></li><li><a class="nounderline abstract_t">Jordaens LJ, Vandenbogaerde JF, Van de Bruaene P, De Buyzere M. Transesophageal echocardiography for insertion of a physiological pacemaker in early pregnancy. Pacing Clin Electrophysiol 1990; 13:955.</a></li><li><a class="nounderline abstract_t">Lau CP, Lee CP, Wong CK, et al. Rate responsive pacing with a minute ventilation sensing pacemaker during pregnancy and delivery. Pacing Clin Electrophysiol 1990; 13:158.</a></li><li><a class="nounderline abstract_t">Coggins DL, Lee RJ, Sweeney J, et al. Radiofrequency catheter ablation as a cure for idiopathic tachycardia of both left and right ventricular origin. J Am Coll Cardiol 1994; 23:1333.</a></li><li><a class="nounderline abstract_t">Klein LS, Shih HT, Hackett FK, et al. Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease. Circulation 1992; 85:1666.</a></li><li><a class="nounderline abstract_t">Calkins H, Kalbfleisch SJ, el-Atassi R, et al. Relation between efficacy of radiofrequency catheter ablation and site of origin of idiopathic ventricular tachycardia. Am J Cardiol 1993; 71:827.</a></li><li><a class="nounderline abstract_t">Timmermans C, Rodriguez LM, Crijns HJ, et al. Idiopathic left bundle-branch block-shaped ventricular tachycardia may originate above the pulmonary valve. Circulation 2003; 108:1960.</a></li><li><a class="nounderline abstract_t">Rodriguez LM, Smeets JL, Timmermans C, Wellens HJ. Predictors for successful ablation of right- and left-sided idiopathic ventricular tachycardia. Am J Cardiol 1997; 79:309.</a></li><li><a class="nounderline abstract_t">Hogarth AJ, Graham LN. Normal heart ventricular tachycardia associated with pregnancy: successful treatment with catheter ablation. Indian Pacing Electrophysiol J 2014; 14:79.</a></li><li><a class="nounderline abstract_t">Driver K, Chisholm CA, Darby AE, et al. Catheter Ablation of Arrhythmia During Pregnancy. J Cardiovasc Electrophysiol 2015; 26:698.</a></li><li><a class="nounderline abstract_t">Pagad SV, Barmade AB, Toal SC, et al. 'Rescue' radiofrequency ablation for atrial tachycardia presenting as cardiomyopathy in pregnancy. Indian Heart J 2004; 56:245.</a></li><li><a class="nounderline abstract_t">Bongiorni MG, Di Cori A, Soldati E, et al. Radiofrequency catheter ablation of atrioventricular nodal reciprocating tachycardia using intracardiac echocardiography in pregnancy. Europace 2008; 10:1018.</a></li><li><a class="nounderline abstract_t">Risius T, Mortensen K, Meinertz T, Willems S. Cluster of multiple atrial tachycardias limited to pregnancy after radiofrequency ablation following senning operation. Int J Cardiol 2008; 123:e48.</a></li><li><a class="nounderline abstract_t">Kanjwal Y, Kosinski D, Kanj M, et al. Successful radiofrequency catheter ablation of left lateral accessory pathway using transseptal approach during pregnancy. J Interv Card Electrophysiol 2005; 13:239.</a></li><li><a class="nounderline abstract_t">Bombelli F, Lagona F, Salvati A, et al. Radiofrequency catheter ablation in drug refractory maternal supraventricular tachycardias in advanced pregnancy. Obstet Gynecol 2003; 102:1171.</a></li><li><a class="nounderline abstract_t">Domínguez A, Iturralde P, Hermosillo AG, et al. Successful radiofrequency ablation of an accessory pathway during pregnancy. Pacing Clin Electrophysiol 1999; 22:131.</a></li><li><a class="nounderline abstract_t">Berruezo A, Díez GR, Berne P, et al. Low exposure radiation with conventional guided radiofrequency catheter ablation in pregnant women. Pacing Clin Electrophysiol 2007; 30:1299.</a></li><li><a class="nounderline abstract_t">Szumowski L, Szufladowicz E, Orczykowski M, et al. Ablation of severe drug-resistant tachyarrhythmia during pregnancy. J Cardiovasc Electrophysiol 2010; 21:877.</a></li><li><a class="nounderline abstract_t">Damilakis J, Theocharopoulos N, Perisinakis K, et al. Conceptus radiation dose and risk from cardiac catheter ablation procedures. Circulation 2001; 104:893.</a></li></ol></div><div id="topicVersionRevision">Topic 13601 Version 31.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11479246" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Prospective multicenter study of pregnancy outcomes in women with heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17572244" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Outcome of pregnancy in women with congenital heart disease: a literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20584777" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Predictors of pregnancy complications in women with congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28154000" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Burden of Arrhythmia in Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7572623" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Effects of pregnancy on first onset and symptoms of paroxysmal supraventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1554546" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Incessant atrial tachycardia accelerated by pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16616027" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9386139" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Risk and predictors for pregnancy-related complications in women with heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16126718" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Risk of complications during pregnancy after Senning or Mustard (atrial) repair of complete transposition of the great arteries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16107486" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Cardiac complications relating to pregnancy and recurrence of disease in the offspring of women with atrioventricular septal defects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16449503" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Pregnancy and delivery in women after Fontan palliation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14557344" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9935279" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Treatment of cardiac arrhythmias during pregnancy: safety considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8103603" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Treatment of cardiac arrhythmias during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30912108" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37211147" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : 2023 HRS expert consensus statement on the management of arrhythmias during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30704579" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Use of Medication for Cardiovascular Disease During Pregnancy: JACC State-of-the-Art Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30165544" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25223771" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Cardiovascular physiology of pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25223771" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Cardiovascular physiology of pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25223771" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Cardiovascular physiology of pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/679433" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Effects of a natural volume overload state (pregnancy) on left ventricular performance in normal human subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/910718" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Cardiac size and performance during pregnancy estimated with echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1130438" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Cardiac performance during pregnancy: serial evaluation using external systolic time intervals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11442917" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Doppler Echocardiography During Pregnancy: Physiological and Abnormal Findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1381296" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Electrophysiological effects of myocardial stretch and mechanical determinants of stretch-activated arrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19286952" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Stretch-activated channel activation promotes early afterdepolarizations in rat ventricular myocytes under oxidative stress.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18367236" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : The role of stretch-activated channels in atrial fibrillation and the impact of intracellular acidosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11090836" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Stretch-activated currents in ventricular myocytes: amplitude and arrhythmogenic effects increase with hypertrophy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19887457" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : The relationship between high resting heart rate and ventricular arrhythmogenesis in patients referred to ambulatory 24 h electrocardiographic recording.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/385865" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Catecholamines. Their role in pregnancy and the development of pregnancy-induced hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7171514" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Plasma noradrenaline and adrenaline levels in normal pregnancy and in pregnancy-induced hypertension.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4005199" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Catecholamine responses to changes in posture during human pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3511708" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Plasma catecholamine responses to physiologic stimuli in normal human pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8476811" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Pressor, heart rate and plasma catecholamine responses to noradrenaline in pregnant and nonpregnant women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6270537" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Regulation of myometrial adrenoreceptors and adrenergic response by sex steroids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3383403" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Delayed afterdepolarizations elicited in vivo by left stellate ganglion stimulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9114764" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Incidence of arrhythmias in normal pregnancy and relation to palpitations, dizziness, and syncope.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19006111" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Frequency and outcome of arrhythmias complicating admission during pregnancy: experience from a high-volume and ethnically-diverse obstetric service.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14285159" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : PAROXYSMAL VENTRICULAR TACHYCARDIA COMPLICATING PREGNANCY.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1550003" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : New-onset ventricular tachycardia during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1761335" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : New onset ventricular tachycardia during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4040617" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Hypertrophic cardiomyopathy and pregnancy: report of a maternal mortality and review of literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12446072" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Risk associated with pregnancy in hypertrophic cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15078417" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Peripartum cardiomyopathy presenting with repetitive monomorphic ventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19471599" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Peripartum cardiomyopathy presenting with ventricular tachycardia: a rare presentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16337730" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Pregnancy in women with arrhythmogenic right ventricular cardiomyopathy/dysplasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24898597" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Arrhythmogenic right ventricular cardiomyopathy in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22889369" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Management of patient with arrhythmogenic right ventricular cardiomyopathy during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16203602" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Arrhythmogenic right ventricular cardiomyopathy with implantable cardioverter defibrillator placement in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17039704" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Arrhythmogenic right ventricular dysplasia in pregnancy: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21740597" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Management of a rare case of arrhythmogenic right ventricular dysplasia in pregnancy: a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14639012" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Arrhythmia and conduction disturbances in patients with congenital heart disease during pregnancy: multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7113941" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1856401" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Pregnancy and congenital heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8873679" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9490239" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Investigators.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20353417" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Electrical storm in Brugada syndrome during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30898243" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Pregnancy in Catecholaminergic Polymorphic Ventricular Tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1115003" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Transmural myocardial infarction during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3312471" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Myocardial infarction in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3966016" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Myocardial infarction during pregnancy: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5425309" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Myocardial infarction with ventricular fibrillation during pregnancy treated by direct current defibrillation with fetal survival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3451239" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Ventricular fibrillation and reinfarction in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3416331" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Acute myocardial infarction and normal coronary arteries in a pregnant woman.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12755529" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Woman with postpartum ventricular tachycardia and hypomagnesemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1442989" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Maternal ventricular tachycardia associated with hypomagnesemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11915995" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Magnesium deficiency during lactation as a precipitant of ventricular tachyarrhythmias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1992697" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Continuous electrocardiographic monitoring in hypertensive crises in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8475977" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Malignant ventricular arrhythmias in eclampsia: a comparison of labetalol with dihydralazine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2810690" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : A case of paroxysmal ventricular tachycardia during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14037442" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Paroxysmal ventricular tachycardia without evident heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2713978" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Nonischemic ventricular tachycardia. Clinical course and long-term follow-up in patients without clinically overt heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7680462" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Radiofrequency catheter ablation of idiopathic recurrent ventricular tachycardia with right bundle branch block, left axis morphology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3379202" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Prognosis of patients with ventricular tachycardia and ventricular fibrillation: role of the underlying etiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2893808" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Effects of beta-adrenergic blockade on verapamil-responsive and verapamil-irresponsive sustained ventricular tachycardias.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2032412" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Conservative treatment of paroxysmal ventricular tachycardia during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6858937" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Idiopathic paroxysmal ventricular tachycardia with a QRS pattern of right bundle branch block and left axis deviation: a unique clinical entity with specific properties.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14629096" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Verapamil-sensitive idiopathic left ventricular tachycardia in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7065395" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : The prolonged Q-T syndrome. A review with anaesthetic implications and a report of two cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15851119" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Identification of a common genetic substrate underlying postpartum cardiac events in congenital long QT syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17010804" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Does pregnancy increase cardiac risk for LQT1 patients with the KCNQ1-A341V mutation?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29084731" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24774391" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : The clinical significance of pregnancy in Brugada syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32216913" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Preventing Complications in Pregnant Women With Cardiac Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/572730" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Management of pregnancy in patients with hypertrophic cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1597233" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Sudden death during pregnancy in hypertrophic cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1988327" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Hypertrophic cardiomyopathy and pregnancy: a report of three cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20883932" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : B-type natriuretic peptide in pregnant women with heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28934836" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Pregnancy in women with hypertrophic cardiomyopathy: data from the European Society of Cardiology initiated Registry of Pregnancy and Cardiac disease (ROPAC).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28268089" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Burden of arrhythmias in peripartum cardiomyopathy: Analysis of 9841 hospitalizations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11817817" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Histopathological correlation of ablation lesions guided by noncontact mapping in a patient with peripartum cardiomyopathy and ventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31836129" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Effect of Pregnancy in Arrhythmogenic Right Ventricular Cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26719359" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7572599" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Treatment of arrhythmias during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7026105" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Special considerations in the use of cardiovascular drugs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14341154" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : DIRECT-CURRENT DEFIBRILLATION DURING PREGNANCY.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5572585" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Repeated cardioversion during pregnancy. Treatment of refractory paroxysmal atrial tachycardia during 3 successive pregnancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3740087" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Cardiopulmonary resuscitation of pregnant women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6409293" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Persistent atrial tachycardia in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5772893" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Paroxysmal ventricular tachycardia associated with pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16377063" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : The impact of maternal cardioversion on fetal haemodynamics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7004155" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Cardioversion and defibrillation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12504980" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Direct current cardioversion during pregnancy should be performed with facilities available for fetal monitoring and emergency caesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7726275" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Pregnancy outcome after gestational exposure to amiodarone in Canada.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7946787" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Successful use of flecainide to treat new onset maternal ventricular tachycardia in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/471380" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : The use of quinidine sulfate throughout pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2473403" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9386142" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Implantable cardioverter-defibrillators and pregnancy: a safe combination?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1497058" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Pregnancy complicated by chronic cardiomyopathy and an automatic implantable cardioverter defibrillator.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23291990" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Safety and efficacy of implantable cardioverter-defibrillator during pregnancy and after delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12930513" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Cardioverter defibrillator implantation in a pregnant woman guided with transesophageal echocardiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1697957" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Transesophageal echocardiography for insertion of a physiological pacemaker in early pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1689831" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Rate responsive pacing with a minute ventilation sensing pacemaker during pregnancy and delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8176091" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Radiofrequency catheter ablation as a cure for idiopathic tachycardia of both left and right ventricular origin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1572025" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8456762" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Relation between efficacy of radiofrequency catheter ablation and site of origin of idiopathic ventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14530199" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Idiopathic left bundle-branch block-shaped ventricular tachycardia may originate above the pulmonary valve.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9036750" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Predictors for successful ablation of right- and left-sided idiopathic ventricular tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24669106" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Normal heart ventricular tachycardia associated with pregnancy: successful treatment with catheter ablation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25828853" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Catheter Ablation of Arrhythmia During Pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15584571" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : 'Rescue' radiofrequency ablation for atrial tachycardia presenting as cardiomyopathy in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18460548" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Radiofrequency catheter ablation of atrioventricular nodal reciprocating tachycardia using intracardiac echocardiography in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17349700" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Cluster of multiple atrial tachycardias limited to pregnancy after radiofrequency ablation following senning operation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16177852" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Successful radiofrequency catheter ablation of left lateral accessory pathway using transseptal approach during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14607046" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Radiofrequency catheter ablation in drug refractory maternal supraventricular tachycardias in advanced pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9990613" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Successful radiofrequency ablation of an accessory pathway during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17897139" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Low exposure radiation with conventional guided radiofrequency catheter ablation in pregnant women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20158563" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Ablation of severe drug-resistant tachyarrhythmia during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11514375" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Conceptus radiation dose and risk from cardiac catheter ablation procedures.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
